Talking About Dementia – Understanding Risk, Reducing Risk

Saturday, September 26, 2026 10:00 AM - 12:00 PM
Delta Hotels by Marriott Calgary South, 135 Southland Drive Southeast, Calgary, AB T2J 5X5
$10
Join us to explore dementia risk reduction, brain health, and the truth behind common medical myths.

Join us for an engaging and accessible conversation with Dr. Ganesh as we explore what current research tells us about dementia risk reduction and brain health. Together, we'll unpack common myths and medical misinformation, discuss the factors that influence dementia risk, and explore practical ways to support lifelong brain health. Whether you're looking to learn for yourself or someone you care about, this session offers reliable information, practical insights, and an opportunity to ask questions.

About Dr Aravind Ganesh

Dr Aravind Ganesh is a Vascular and Cognitive Neurologist and Vice Chair (Equity, Diversity, Inclusion, and Accessibility) of the Department of Clinical Neurosciences at the University of Calgary, as well as a member of the Hotchkiss Brain Institute, the Mathison Centre for Mental Health Research and Education, and the O’Brien Institute for Public Health. He completed his MD at the University of Calgary, followed by a DPhil in Clinical Neurosciences at the University of Oxford’s Centre for Prevention of Stroke and Dementia as a Rhodes scholar. He completed his neurology residency in Calgary, followed by a combined fellowship in stroke and cognitive neurology, funded by Alberta Innovates and the Canadian Institutes of Health Research. He is a Fellow of the Canadian Stroke Consortium, and is actively involved in the development of best-practice guidelines for stroke and dementia care. His clinical research is focused on understanding the natural history, risk stratification, prevention, and treatment of stroke and cognitive impairment using multidisciplinary methods including neuroimaging, clinical epidemiology, artificial intelligence, mixed-methods research, and clinical trials. His lab also leads the development and testing of innovative applications and devices for the diagnosis and treatment of dementia and stroke. He has received New Investigator Awards from the Heart and Stroke Foundation of Canada and the Alzheimer Society of Canada, as well as the Henry J. M. Barnett Scholarship and the Brain Canada Future Leaders in Brain Research award for outstanding contributions as a researcher in the field of dementia and stroke.